OKYO Pharma (OKYO) Operating Leases (2021)
OKYO Pharma (OKYO) reported Operating Leases of $98760.0 for Q1 2021.
OKYO Pharma (OKYO) Operating Leases (2021) Analysis & Trends
OKYO Pharma (OKYO) has 1 years of Operating Leases data on file, last reported at $98760.0 in Q1 2021.
- Operating Leases for Q1 2021 came in at $98760.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2021 was $98760.0 (changed N/A YoY), and the FY2021 annual result was $98760.0, changed N/A from the prior year.
- Operating Leases steadied at $98760.0 in Q1 2021 per OKYO's latest filing.
- Over five years, Operating Leases peaked at $98760.0 in Q1 2021 and troughed at $98760.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | OKYO Pharma | 240.90 Mn | 236.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 98,760.00 |